Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Totalis and Alopecia Universalis: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study

Main Article Content

Xingqi Zhang
Nina Magnolo
Masato Mizuashi
Natasha Mesinkovska
Jerry Shapiro
Fan Zhang
Urs Kerkmann
Ernest Law
Robert Wolk
Gregor Schaefer

Keywords

ritlecitinib, efficacy, alopecia totalis, alopecia universalis, ALLEGRO, clinical trial

References

1. Islam N, et al. Autoimmun Rev. 2015;14:81-89

2. Delamere FM, et al. Cochrane Database Syst Rev. 2008;16:CD004413

3. Olsen EA, et al. J Am Acad Dermatol. 2018;79:470-478

4. King B, et al. Presented at: EADV 2021

Most read articles by the same author(s)